Skip to content

ORBIMED ADVISORS LLC: AVBP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on AVBP, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 3,027,328 AVBP shares at 2026-09-30 per its 13F-HR filed 2026-11-16, and reported 2,875,962 shares, 5.8%, in a 13D/A filed 2026-10-08.

Estimated current stake: 2,875,962 shares, 5.8% of the class

Estimated from 13D/A of 2026-10-08. As of 2026-10-06, 13D/A 0000947871-26-000931.

Shares are the reporting group's aggregate and may include entities that do not file a 13F.

The reporting persons may hold separate positions, so the group total can be higher than the largest row.

Percent of portfolio stays on the 13F for 2026-09-30.

  1. event date2026-10-06
    13D/A 2,875,962 shares
    Share basis changed not comparable

    5.8% of the class. Different basis (group aggregate from 13D/A).

    13D/A 0000947871-26-000931 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    A 13D/G states the aggregate of its reporting persons, which may include entities that do not file a 13F.

    The reporting persons may hold separate positions, so the group total can be higher than the largest row.

  2. period ended2026-09-30
    13F 3,027,328 shares
    Change vs previous 13F 0 shares

    1.68% of the 13F portfolio, value $91,667,492.

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

  3. period ended2026-06-30
    13F 3,027,328 shares
    Change vs previous 13F 0 shares

    1.99% of the 13F portfolio, value $105,169,375.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2026-03-31
    13F 3,027,328 shares
    Change vs previous 13F 0 shares

    1.52% of the 13F portfolio, value $69,840,457.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-12-31
    13F 3,027,328 shares
    Change vs previous 13F 0 shares

    1.25% of the 13F portfolio, value $60,909,839.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-09-30
    13F 3,027,328 shares
    Change vs previous 13F 0 shares

    1.34% of the 13F portfolio, value $55,854,202.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2025-06-30
    13F 3,027,328 shares
    Change vs previous 13F 0 shares

    1.66% of the 13F portfolio, value $65,904,931.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2025-03-31
    13F 3,027,328 shares
    Change vs previous 13F 0 shares

    1.34% of the 13F portfolio, value $55,975,295.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  9. period ended2024-12-31
    13F 3,027,328 shares
    Change vs previous 13F not available

    1.67% of the 13F portfolio, value $80,648,018.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).